Can omega-3 fatty acids beat back cancer? Maybe not

Let the fight continue to rage over whether drugs and supplements made from omega-3 fatty acids have any therapeutic effect. We’ve told you about recent research that suggests that fish oil and walnuts (both of which have omega-3s) could combat leukemia and reduce the risk of prostate cancer, respectively, and form the basis of potential new drugs. Now comes a potentially contradictory French study that is far from conclusive on the matter. The study looked at Vitamin B and omega-3 supplements, concluding that they did not "significantly" increase the cancer risk in men who were taking both because of cardiovascular health issues. On the other hand, women with previous cardiovascular problems seemed to have a higher cancer risk after 5 years of taking both compounds. The debate, sadly, goes on. Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.